Coumermycin analogs as chemical dimerizers of chimeric proteins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S530000, C514S427000

Reexamination Certificate

active

06916846

ABSTRACT:
Coumermycin analogs of general formula I:wherein X, a linking group, is selected from the group consisting of alkyl, aryl, diaryl, substituted alkyl, substituted aryl, alkyl with hereroatoms in the chain, heteroaryl, cyclic and bicyclic alkyl, and a combination of alkyl, aryl and heteroaryl substituents. The compounds are suitable for use as chemical dimerizers of chimeric proteins.

REFERENCES:
patent: 3627886 (1971-12-01), Newmark
patent: 5830462 (1998-11-01), Crabtree et al.
patent: 5834266 (1998-11-01), Crabtree et al.
patent: WO 99/35155 (1999-07-01), None
M. A. Farrar et al., Activation of the Raf-1 Kinase Cascade by Coumermycin Induced Dimerization, Nature, vol. 383, pp. 178-181, Sep. 12, 1996.
T. P. Curran et al., J. Org. Chem., vol. 61, p. 9068, 1996.
P. Laurin et al., Bioorg. Med. Chem. Lett., vol. 9, p. 2079, 1999.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Coumermycin analogs as chemical dimerizers of chimeric proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Coumermycin analogs as chemical dimerizers of chimeric proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Coumermycin analogs as chemical dimerizers of chimeric proteins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3395499

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.